Track topics on Twitter Track topics that are important to you
Healthcare regulations such as the Protecting Access to Medicare Act (PAMA) and General Data Protection Regulations (GDPR) continue to evolve and challenge the laboratory industry. To remain viable in this changing landscape, every clinical and pathology lab must understand and respond to these challenges by learning and implementing effective cost-control strategies, as well as by developing and deploying targeted lab services that deliver value and earn reimbursements. At the 24th annual Executive War College Conference on Laboratory & Pathology Management, executives from XIFIN, Inc. will provide insights on how labs can achieve this – highlighting strategies that leverage informatics, artificial intelligence, machine learning and more. The conference will occur April 30 – May 1, 2019, in New Orleans, LA.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190416005674/en/
Lâle White, executive chairman & CEO of XIFIN, will provide insight into current private payor outlook on pricing, and effective strategies labs can implement in response to private insurers making aggressive price cuts beyond what the PAMA schedule dictates. (Photo: Business Wire)
On April 30th, Lâle White, executive chairman & CEO of XIFIN, will be closing out the first day with a general session titled “Ugly Truth About Payers & PAMA: What Labs Can Expect and How to Respond.” During the session, she will share insights about private insurers making aggressive price cuts beyond what the PAMA schedule dictates, and what strategies that labs have implemented in response have worked and which have not. Other XIFIN leaders, as well as leaders from Etyon and Pathology Practice Advisors, LLC, will also be presenting their insights on lab revenue enhancement strategies. The following is a full schedule of the sessions:
Tuesday, April 30
Wednesday, May 1
Thursday, May 2
“The Executive War College brings together more than 800 clinical laboratory executives, pathologists and industry leaders, providing attendees with innovative strategies on how labs can best prepare themselves for the future,” stated Robert Michel, editor-in-chief of The Dark Report and president of The Dark Intelligence Group, Inc. “Given the deep experience and daily interaction XIFIN has with hundreds of the nation's most successful medical laboratory organizations, Lâle White and other company leaders have unique, useful knowledge to share that labs of all sizes and types can use to maximize their financial value, especially at a time when so much is changing with healthcare in the United States.”
Precision Medicine Institute Symposium 2019
In addition to the Executive War College conference, XIFIN will have a presence at the 2019 Precision Medicine Institute Symposium, also taking place in New Orleans, LA, from May 2 – 3. Precision medicine is poised to transform clinical care, and this event will provide timely insights on how to develop the right precision medicine strategy for today’s health networks. On Tuesday, May 2, at 2:10 PM CT, Lori Anderson, product marketing manager at XIFIN, will be presenting at the event on the topic of “Precision Medicine Informatics: What Hospitals, Physicians, and Payers Need to Know About Challenges, Approaches, and Best Practices.”
About XIFIN, Inc.
XIFIN is a healthcare information technology company that leverages diagnostic information to improve the quality and economics of healthcare. The company's cloud-based technology facilitates connectivity and workflow automation for accessing and sharing clinical and financial diagnostic data, linking healthcare stakeholders in the delivery and reimbursement of care. To learn more, visit www.XIFIN.com, follow XIFIN on Twitter and LinkedIn, or subscribe to the XIFIN blog.
Julie Sculley, 617.986.5730
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...